 In January 2016, the Brazilian Association for Collective Health ("Abrasco"; ) criticized the introduction of pyriproxyfen in Brazil.Abrasco demanded the "immediate suspension of [use of] pyriproxyfen and all growth inhibitors ... in drinking water.